Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Non-Small-Cell Lung × Observation × Clear all

Status

Active not recruiting 5 Recruiting 3 Not yet recruiting 3 Completed 3 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 3 Anus Neoplasms 2 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Squamous Intraepithelial Lesions 1 Sleep Apnea, Obstructive 1 Sarcoma 1 Rectal Neoplasms 1 Precancerous Conditions 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Oropharyngeal Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Leukemia, B-Cell 1 Hypertension 1 Hypercholesterolemia 1 Homosexuality 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Cushing Syndrome 1

Interventions

Carboplatin 89 Pemetrexed 78 Docetaxel 69 pembrolizumab 65 Paclitaxel 61 Cisplatin 61 Erlotinib Hydrochloride 46 Radiotherapy 39 Gemcitabine 35 Nivolumab 29 Bevacizumab 29 Radiosurgery 21 atezolizumab 19 durvalumab 16 Cyclophosphamide 16 Vinorelbine 12 Taxes 12 Radiation 12 Etoposide 12 130-nm albumin-bound paclitaxel 11 avelumab 10 Drug Therapy 10 Albumin-Bound Paclitaxel 10 Cetuximab 9 spartalizumab 8 Vorinostat 8 Ipilimumab 8 Gefitinib 8 Dexamethasone 8 trametinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05032352 2022-11-14

PADMA

Insight Molecular Diagnostics

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡